AARD

Aardvark Therapeutics
AARD

Upgrade to unlock
Buy
Hold
Sell

3 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$26
103% upside
High target

3 analyst ratings

positive
0  neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
Oppenheimer
Oppenheimer
Leland Gershell
0% 1-yr AARD win rate
23 Dec ‘25 1 month ago
William Blair
William Blair
Andy Hsieh
0% 1-yr AARD win rate
12 Dec ‘25 1 month ago
RBC Capital
RBC Capital
Brian Abrahams
60% 1-yr AARD win rate
14 Nov ‘25 2 months ago
BTIG
BTIG
Jeet Mukherjee
100% 1-yr AARD win rate
7 Nov ‘25 2 months ago